Pinnacle Wealth Management Advisory Group, LLC Gilead Sciences, Inc. Transaction History
Pinnacle Wealth Management Advisory Group, LLC
- $962 Million
- Q2 2024
A detailed history of Pinnacle Wealth Management Advisory Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pinnacle Wealth Management Advisory Group, LLC holds 31,154 shares of GILD stock, worth $2.61 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
31,154
Previous 17,389
79.16%
Holding current value
$2.61 Million
Previous $1.27 Million
67.87%
% of portfolio
0.22%
Previous 0.14%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.66 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.39 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.07 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.97 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $105B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...